Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:16353714rdf:typepubmed:Citationlld:pubmed
pubmed-article:16353714lifeskim:mentionsumls-concept:C0038002lld:lifeskim
pubmed-article:16353714lifeskim:mentionsumls-concept:C0035020lld:lifeskim
pubmed-article:16353714lifeskim:mentionsumls-concept:C1302234lld:lifeskim
pubmed-article:16353714lifeskim:mentionsumls-concept:C0085973lld:lifeskim
pubmed-article:16353714lifeskim:mentionsumls-concept:C0007320lld:lifeskim
pubmed-article:16353714lifeskim:mentionsumls-concept:C0580836lld:lifeskim
pubmed-article:16353714lifeskim:mentionsumls-concept:C0720803lld:lifeskim
pubmed-article:16353714pubmed:issue4lld:pubmed
pubmed-article:16353714pubmed:dateCreated2005-12-15lld:pubmed
pubmed-article:16353714pubmed:abstractTextThe Hyperreactive Malarial Splenomegaly Syndrome (HMS) originally called the tropical splenomegaly syndrome (TSS) or Big spleen disease refers to cases of splenomegaly in the tropics for which no cause was found despite thorough investigation. It is restricted to the malarial belt, yet there are few reports on HMS in Nigeria, probably due to a low index of suspicion and non-availability of laboratory facilities to determine titres of malarial antibodies. The objective of this paper is to highlight the features, management, risk of relapse and prognosis of HMS.lld:pubmed
pubmed-article:16353714pubmed:languageenglld:pubmed
pubmed-article:16353714pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16353714pubmed:citationSubsetIMlld:pubmed
pubmed-article:16353714pubmed:statusMEDLINElld:pubmed
pubmed-article:16353714pubmed:issn1115-2613lld:pubmed
pubmed-article:16353714pubmed:authorpubmed-author:OtaigbeB EBElld:pubmed
pubmed-article:16353714pubmed:authorpubmed-author:EmurenLLlld:pubmed
pubmed-article:16353714pubmed:issnTypePrintlld:pubmed
pubmed-article:16353714pubmed:volume14lld:pubmed
pubmed-article:16353714pubmed:ownerNLMlld:pubmed
pubmed-article:16353714pubmed:authorsCompleteYlld:pubmed
pubmed-article:16353714pubmed:pagination447-9lld:pubmed
pubmed-article:16353714pubmed:dateRevised2011-8-25lld:pubmed
pubmed-article:16353714pubmed:meshHeadingpubmed-meshheading:16353714...lld:pubmed
pubmed-article:16353714pubmed:meshHeadingpubmed-meshheading:16353714...lld:pubmed
pubmed-article:16353714pubmed:meshHeadingpubmed-meshheading:16353714...lld:pubmed
pubmed-article:16353714pubmed:meshHeadingpubmed-meshheading:16353714...lld:pubmed
pubmed-article:16353714pubmed:meshHeadingpubmed-meshheading:16353714...lld:pubmed
pubmed-article:16353714pubmed:meshHeadingpubmed-meshheading:16353714...lld:pubmed
pubmed-article:16353714pubmed:meshHeadingpubmed-meshheading:16353714...lld:pubmed
pubmed-article:16353714pubmed:meshHeadingpubmed-meshheading:16353714...lld:pubmed
pubmed-article:16353714pubmed:articleTitleFatal relapse of hyperreactive malarial splenomegaly (HMS) in a 10-year old Nigerian female--a case report.lld:pubmed
pubmed-article:16353714pubmed:affiliationDepartment of Paediatrics, University of Port Harcourt Teaching Hospital, Nigeria.lld:pubmed
pubmed-article:16353714pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:16353714pubmed:publicationTypeCase Reportslld:pubmed